ADC Therapeutics SA

Ownership Transactions Reported by 16 Insiders

Symbol
ADCT on NYSE
Location
Biopole, Route De La Corniche 3 B, Epalinges, Switzerland

Insiders trading volume in the past year

ADC Therapeutics SA executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Redmile Group, LLC 10%+ Owner $287M +$97.3M +51.3% Jun 11, 2025
Hans Peter Wild 10%+ Owner $14.3M May 15, 2025
Ameet Mallik Chief Executive Officer, Director $2M May 6, 2025
Jose Carmona Chief Financial Officer $872K Feb 13, 2025
Peter Hug Director $789K Jun 13, 2025
Mohamed Zaki Chief Medical Officer $745K Feb 13, 2025
Peter Graham Chief Legal Officer $658K Feb 13, 2025
Viviane Monges Director $516K Jun 13, 2025
Victor Sandor Director $388K Jun 13, 2025
Jean Pierre Bizzari Director $383K Jun 13, 2025
Ron Squarer Director $335K Jun 13, 2025
Robert Azelby Director $288K Jun 13, 2025
Thomas Pfisterer Other* $254K May 15, 2025
Lisa Kallebo Chief Accounting Officer $125K Feb 13, 2025
Timothy Coughlin Director $53.6K Jun 3, 2025
Tyrell Rivers Director Jan 2, 2024

Recent Insider Transactions by Companies or Individuals for ADC Therapeutics SA

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.